Table of Contents

company-logo

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx as a cardioprotective therapy to reduce cardiovascular and respiratory events in patients hospitalized with COVID-19, as well as to evaluate the efficacy and safety of CardiolRx in acute myocarditis. The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.

Cardiol Therapeutics Dividend Announcement

• Cardiol Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Cardiol Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Cardiol Therapeutics Dividend History

Cardiol Therapeutics Dividend Yield

Cardiol Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Cardiol Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Cardiol Therapeutics Financial Ratios

P/E ratio-6.39
PEG ratio0.14
P/B ratio12.21
ROE-119.09%
Payout ratio0.00%
Current ratio2.39
Quick ratio2.39
Cash Ratio2.22

Cardiol Therapeutics Dividend FAQ

Does Cardiol Therapeutics stock pay dividends?
Cardiol Therapeutics does not currently pay dividends to its shareholders.
Has Cardiol Therapeutics ever paid a dividend?
No, Cardiol Therapeutics has no a history of paying dividends to its shareholders. Cardiol Therapeutics is not known for its dividend payments.
Why doesn't Cardiol Therapeutics pay dividends?
There are several potential reasons why Cardiol Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Cardiol Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Cardiol Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Cardiol Therapeutics a dividend aristocrat?
Cardiol Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Cardiol Therapeutics a dividend king?
Cardiol Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Cardiol Therapeutics a dividend stock?
No, Cardiol Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Cardiol Therapeutics stocks?
To buy Cardiol Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Cardiol Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.